GPGloria Shir-Wey Pang

Gloria Shir-Wey Pang

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article


Gloria Shir-Wey Pang has a total of 34 co-authors. Here are the top co-authors by number of shared publications:

  • Joanna Yuet-Ling Tung

    Department of Paediatrics and Adolescent Medicine , Hong Kong Children’s Hospital , Hong Kong , China

    2 shared publications
  • Angela Mo-Kit Chan

    Department of Paediatrics and Adolescent Medicine , Alice Ho Miu Ling Nethersole Hospital , Hong Kong , P.R. China

    1 shared publication
  • Anthony Pak Yin Liu

    Division of Hematology and Oncology, Department of Pediatrics, The Hospital for Sick Children , Toronto

    1 shared publication
  • Antony Chun-Cheung Fu

    Department of Paediatrics and Adolescent Medicine , Princess Margaret Hospital , Hong Kong , P.R. China

    1 shared publication
  • Betty Wai-Man But

    Department of Paediatrics , Queen Elizabeth Hospital , Hong Kong , P.R. China

    1 shared publication
  • Ching-Yin Lee

    Department of Paediatrics , Caritas Medical Centre , Hong Kong , P.R. China

    1 shared publication

Latest Publications

  • Review on the screening of urine glucose for early diagnosis of type 2 diabetes mellitus in school children and adolescents with obesity in Hong Kong

    by Gloria Shir-Wey Pang, Thomas Wai-Hung Chung, Heather Hiu-Ting Choy, Ching-Yin Lee, Joanna Yuet-Ling Tung, Antony Chun-Cheung Fu, Jennifer Wing-Yan Tsang, Ho-Chung Yau, Kiran M. Belaramani, Lap-Ming Wong, et al.

    Objectives Obesity and type 2 diabetes mellitus (T2DM) are growing health concerns. Since 2005, Student Health Service (SHS) and Hong Kong Paediatric Society formulated a protocol on urine glucose screening (UGS) for early diagnosis of T2DM in students with obesity in Hong Kong. This study reviews students with T2DM captured by this screening program and compare the data with the Hong Kong Children Diabetes Registry (HKCDR) database, to see if the UGS program facilitates early diagnosis of T2DM. Methods Students between the ages of 10–18 years old with age- and sex-specific body mass index (BMI) >97th percentile who attended SHS between the school years from 2005/06 to 2017/18 were recruited for UGS. Those tested positive for random urine glucose underwent diagnostic testing for T2DM according to ADA guidelines. Demographic data and investigatory results from UGS and HKCDR within the same time period were compared. Results 216,526 students completed UGS in the said period; 415 (0.19 %) students were tested positive for urine glucose of which 121 students were diagnosed with T2DM. UGS picked up 23 % of the newly diagnosed T2DM cases. When compared to the HKCDR database, students diagnosed via UGS were significantly younger, less obese, and had fewer diabetic related complications. The negative predictive value of UGS is high and can effectively rule out T2DM. Conclusions Urine glucose screening is an inexpensive and simple test that allows for early diagnosis of T2DM among obese school students. Other methods including POCT HbA1c can be explored to improve program effectiveness.


  • Open Access

    Incidence and Predictors for Oncologic Etiologies in Chinese Children with Pituitary Stalk Thickening

    by Mario W. T. Li, Sarah W. Y. Poon, Claudia Cheung, Chris K. C. Wong, Matthew M. K. Shing, Terry T. W. Chow, Samantha L. K. Lee, Gloria S. W. Pang, Elaine Y. W. Kwan, Grace W. K. Poon, et al.

    Background: With the increasing use of magnetic resonance imaging (MRI) in the evaluation of children with endocrine disorders, pituitary stalk thickening (PST) poses a clinical conundrum due to the potential for underlying neoplasms and challenges in obtaining a tissue biopsy. The existing literature suggests Langerhans cell histiocytosis (LCH) to be the commonest (16%) oncologic cause for PST, followed by germ cell tumors (GCTs, 13%) (CCLG 2021). As the cancer epidemiology varies according to ethnicity, we present herein the incidence and predictors for oncologic etiologies in Hong Kong Chinese children with PST. Methods: Based on a territory-wide electronic database, we reviewed patients aged < 19 years who presented to three referral centers with endocrinopathies between 2010 and 2022. Records for patients who underwent at least one MRI brain/pituitary were examined (n = 1670): those with PST (stalk thickness ≥ 3 mm) were included, while patients with pre-existing cancer, other CNS and extra-CNS disease foci that were diagnostic of the underlying condition were excluded. Results: Twenty-eight patients (M:F = 10:18) were identified. The median age at diagnosis of PST was 10.9 years (range: 3.8–16.5), with central diabetes insipidus (CDI) and growth hormone deficiency (GHD) being the most frequent presenting endocrine disorders. At a median follow-up of 4.8 years, oncologic diagnoses were made in 14 patients (50%), including 13 GCTs (46%; germinoma = 11, non-germinoma = 2) and one LCH (4%). Among patients with GCTs, 10 were diagnosed based on histology, two by abnormal tumor markers and one by a combination of histology and tumor markers. Three patients with germinoma were initially misdiagnosed as hypophysitis/LCH. The cumulative incidence of oncologic diagnoses was significantly higher in boys and patients with PST at presentation ≥6.5 mm, CDI or ≥2 pituitary hormone deficiencies at presentation and evolving hypopituitarism (all p < 0.05 by log-rank). Conclusions: A higher rate of GCTs was observed in Chinese children with endocrinopathy and isolated PST. The predictors identified in this study may guide healthcare providers in Asia in clinical decision making. Serial measurement of tumor markers is essential in management.